Z-ALA-ALA-OME

We are Z-ALA-ALA-OME CAS:2483-51-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Z-ALA-ALA-OME
CAS.NO: 2483-51-4
Molecular Formula: C15H20N2O5
Molecular Weight: 308.33000

Synonyms:
Z-L-Ala-L-Ala-OMe
Z-L-ALANYL-L-ALANINE METHYL ESTER
Z-Ala-Ala-OCH3
Cbz-Ala-Ala-OMe

Physical and Chemical Properties:
Density:/
Boiling point:/
Melting point: 93-94 °C
Flash point:/
Refractive index: /

Specification:
Appearance: White powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:-15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

Z-ALA-ALA-OME


Related News: These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.octylbenzene It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.2,4-dibromo-1-methoxybenzene The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen’s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.2- (4'-cloro [1,1'-bifenil] -3-il) -4,6-difenil-1,3,5-triazina CAS:1443049-85-1 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.

Related Products
Product Name
2-Fluoro-3-methyl-5-nitropyridine View Details
2-(4-CHLOROPHENOXY)ANILINE View Details
Acetyl Tetrapeptide-5 View Details
o-Toluidine manufacturer H-LYS-LYS-LYS-OH manufacturer 3-Pyridylacetic Acid Hydrochloride manufacturer 2-(4-chlorophenyl)hexanenitrile manufacturer 3,4-Dichlorophenylboronic acid manufacturer